Au­rinia ap­points founder to board in hand­shake with MKT Cap­i­tal

As Au­rinia Phar­ma­ceu­ti­cals ex­plores a po­ten­tial sale and re­fresh­es its board fol­low­ing push­back from MKT Cap­i­tal and an­oth­er in­vestor group, the drug­mak­er has agreed to name its founder Robert Fos­ter to a di­rec­tor seat.

Au­rinia said Thurs­day it will co­op­er­ate with MKT Cap­i­tal un­der an agree­ment that they’ve hashed out. In a state­ment, chair Daniel Billen called the process a “con­struc­tive col­lab­o­ra­tion,” and MKT founder An­toine Khal­ife said the firm is “en­cour­aged” by the “pro­duc­tive dis­cus­sions” with the board.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER